Skip to main content
. 2017 Sep 21;12(9):e0184843. doi: 10.1371/journal.pone.0184843

Fig 2. Characterization of cGAMP FP assay.

Fig 2

(A) mAb titration with Cy5-cGAMP (2 nM); (B) competition of Cy5-cGAMP (2 nM) binding to mAb 80–2 with: cGAMP, cAMP, cGMP, ATP or GTP; (C) Z’ results of FP assay in subset screen; (D) Distribution of compound activity from subset screen.